{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:09:30Z","timestamp":1740146970559,"version":"3.37.3"},"reference-count":20,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T00:00:00Z","timestamp":1733443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 EY019587"],"award-info":[{"award-number":["R01 EY019587"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30 EY016665"],"award-info":[{"award-number":["P30 EY016665"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["S10 OD026957"],"award-info":[{"award-number":["S10 OD026957"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P51RR000167\/P51OD011106"],"award-info":[{"award-number":["P51RR000167\/P51OD011106"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001818","name":"Research to Prevent Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001818","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>The optical imaging agent TcapQ488 has enabled imaging of retinal ganglion cell (RGC) injury in vivo in rodents and has potential as an effective diagnostic probe for early detection and intervention monitoring in glaucoma patients. In the present study, we investigated TcapQ488 in non-human primates (NHPs) to identify labeling efficacy and early signals of injured RGC, to determine species-dependent changes in RGC probe uptake and clearance, and to determine dose-limiting toxicities. Doses of 3, 6, and 12 nmol of TcapQ488 were delivered intravitreally to normal healthy NHP eyes and eyes that had undergone hemiretinal endodiathermy axotomy (HEA) in the inferior retina. Post-injection fundus fluorescence imaging using a Spectralis imaging platform (Heidelberg Engineering) documented TcapQ488 activation in RGC cell bodies. Optical coherence tomography (OCT), slit-lamp examinations, intraocular pressure measurements, and visual electrophysiology testing were performed to monitor probe tolerability. For comparison, a negative control, non-cleavable, non-quenched probe (dTcap488, 6 nmol), was delivered intravitreally to a normal healthy eye. In normal healthy eyes, intravitreal injection of 3 nmol of TcapQ488 was well-tolerated, while 12 nmol of TcapQ488 to the healthy eye caused extensive probe activation in the ganglion cell layer (GCL) and eventual retinal nerve fiber layer thinning. In HEA eyes, the HEA procedure followed by intravitreal TcapQ488 (3 nmol) injection resulted in probe activation within cell bodies in the GCL, confined to the HEA-treated inferior retina, indicating cell injury and slow axonal transport in the GCL. However, in contrast to rodents, a vitreal haze that lasted 2\u201312 weeks obscured rapid high-resolution imaging of the fundus. By contrast, intravitreal TcapQ488 injection prior to the HEA procedure led to minimal probe labeling in the GCL. The results of the dTcap488 control experiments indicated that fast axonal transport carried the probe out of the retina after cell body uptake. No evidence of pan-retinal toxicity or loss of retino-cortical function was detected in any of the three NHPs tested. Overall, these data provide evidence of TcapQ488 activation, without toxicity, in NHP HEA eyes that had been intravitreally injected with 3 nmol of the probe. Compared to rodents, unexpectedly rapid axonal transport in the NHPs reduced the capacity to visualize RGC cell bodies and axons through the backdrop of an intravitreal haze. Nonetheless, although intravitreal clearance rates did not scale to NHPs, HEA-induced reductions in axonal transport enhanced probe visualization in the cell body.<\/jats:p>","DOI":"10.1371\/journal.pone.0313579","type":"journal-article","created":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:22:58Z","timestamp":1733509378000},"page":"e0313579","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["In vivo scanning laser fundus and high-resolution OCT imaging of retinal ganglion cell injury in a non-human primate model with an activatable fluorescent-labeled TAT peptide probe"],"prefix":"10.1371","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-2874-5610","authenticated-orcid":true,"given":"Xudong","family":"Qiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8647-0975","authenticated-orcid":true,"given":"Seth T.","family":"Gammon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carol","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1989-4417","authenticated-orcid":true,"given":"Federica","family":"Pisaneschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlene B. Y.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Ver Hoeve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven W.","family":"Millward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edward M.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0687-373X","authenticated-orcid":true,"given":"T. Michael","family":"Nork","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul L.","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2120-7217","authenticated-orcid":true,"given":"David","family":"Piwnica-Worms","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2024,12,6]]},"reference":[{"issue":"5035","key":"pone.0313579.ref001","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1126\/science.1957169","article-title":"Optical coherence tomography","volume":"254","author":"D Huang","year":"1991","journal-title":"Science"},{"key":"pone.0313579.ref002","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-3-030-16638-0_3","volume-title":"High Resolution Imaging in Microscopy and Ophthalmology: New Frontiers in Biomedical Optics","author":"S Aumann","year":"2019"},{"issue":"1\u20132","key":"pone.0313579.ref003","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/sj.neo.7900071","article-title":"Optical coherence tomography: an emerging technology for biomedical imaging and optical biopsy","volume":"2","author":"JG Fujimoto","year":"2000","journal-title":"Neoplasia"},{"issue":"2","key":"pone.0313579.ref004","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/eye.2016.295","article-title":"Assessing retinal ganglion cell damage","volume":"31","author":"CA Smith","year":"2017","journal-title":"Eye (Lond)"},{"issue":"3","key":"pone.0313579.ref005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1167\/iovs.62.3.34","article-title":"Quantification of Retinal Ganglion Cell Morphology in Human Glaucomatous Eyes","volume":"62","author":"Z Liu","year":"2021","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"48","key":"pone.0313579.ref006","doi-asserted-by":"crossref","first-page":"12803","DOI":"10.1073\/pnas.1711734114","article-title":"Imaging and quantifying ganglion cells and other transparent neurons in the living human retina","volume":"114","author":"Z Liu","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0313579.ref007","doi-asserted-by":"crossref","first-page":"100976","DOI":"10.1016\/j.preteyeres.2021.100976","article-title":"Detecting retinal cell stress and apoptosis with DARC: Progression from lab to clinic","volume":"86","author":"MF Cordeiro","year":"2022","journal-title":"Prog Retin Eye Res"},{"issue":"9","key":"pone.0313579.ref008","article-title":"Apoptosis Detection in Retinal Ganglion Cells Using Quantitative Changes in Multichannel Fluorescence Colocalization","volume":"12","author":"X Qiu","year":"2022","journal-title":"Biosensors (Basel)"},{"key":"pone.0313579.ref009","first-page":"190","article-title":"A novel, small, cell-permeable, activatable fluorescence probe for imaging caspase 3 and 7 activity","volume":"3","author":"K Bullok","year":"2004","journal-title":"Mol Imaging"},{"key":"pone.0313579.ref010","doi-asserted-by":"crossref","first-page":"5404","DOI":"10.1021\/jm050008p","article-title":"Synthesis and characterization of a small, membrane-permeant, caspase-activatable far-red fluorescent peptide for imaging apoptosis","volume":"48","author":"K Bullok","year":"2005","journal-title":"J Med Chem"},{"key":"pone.0313579.ref011","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1167\/iovs.05-1470","article-title":"Selective cell uptake of modified Tat peptide-fluorophore conjugates in rat retina in ex vivo and in vivo models","volume":"47","author":"EM Barnett","year":"2006","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"23","key":"pone.0313579.ref012","doi-asserted-by":"crossref","first-page":"9391","DOI":"10.1073\/pnas.0812884106","article-title":"Single-cell imaging of retinal ganglion cell apoptosis with a cell-penetrating, activatable peptide probe in an in vivo glaucoma model","volume":"106","author":"EM Barnett","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"pone.0313579.ref013","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1021\/bc800516n","article-title":"An improved cell-penetrating, caspase-activatable, near-infrared fluorescent peptide for apoptosis imaging","volume":"20","author":"D Maxwell","year":"2009","journal-title":"Bioconjug Chem"},{"issue":"9","key":"pone.0313579.ref014","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1021\/bc300036z","article-title":"Caspase-activated cell-penetrating peptides reveal temporal coupling between endosomal release and apoptosis in an RGC-5 cell model","volume":"23","author":"JR Johnson","year":"2012","journal-title":"Bioconjug Chem"},{"key":"pone.0313579.ref015","doi-asserted-by":"crossref","first-page":"e88855","DOI":"10.1371\/journal.pone.0088855","article-title":"Single-cell resolution imaging of retinal ganglion cell apoptosis in vivo using a cell-penetrating caspase-activatable peptide probe","volume":"9","author":"X Qiu","year":"2014","journal-title":"PLoS ONE"},{"issue":"7","key":"pone.0313579.ref016","doi-asserted-by":"crossref","first-page":"911","DOI":"10.4161\/cbt.28880","article-title":"Evaluating new therapies in gastrointestinal stromal tumor using in vivo molecular optical imaging","volume":"15","author":"H Hensley","year":"2014","journal-title":"Cancer Biol Ther"},{"issue":"10","key":"pone.0313579.ref017","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1038\/eye.2015.154","article-title":"Advances in retinal ganglion cell imaging","volume":"29","author":"SI Balendra","year":"2015","journal-title":"Eye (Lond)"},{"issue":"5","key":"pone.0313579.ref018","doi-asserted-by":"crossref","DOI":"10.3390\/cells9051298","article-title":"Axonal Transport as an In Vivo Biomarker for Retinal Neuropathy","volume":"9","author":"LG Le Roux","year":"2020","journal-title":"Cells"},{"issue":"5","key":"pone.0313579.ref019","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1167\/iovs.12-11265","article-title":"Structural and functional effects of hemiretinal endodiathermy axotomy in cynomolgus macaques","volume":"54","author":"RJ Dashek","year":"2013","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"pone.0313579.ref020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/02713683.2024.2397028","article-title":"Development of Microcystoid Macular Degeneration in the Retina of Nonhuman Primates: Time-Course and Associated Pathologies","author":"TCM Lavery","year":"2024","journal-title":"Curr Eye Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0313579","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,6]],"date-time":"2024-12-06T18:23:06Z","timestamp":1733509386000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0313579"}},"subtitle":[],"editor":[{"given":"Tudor C.","family":"Badea","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2024,12,6]]},"references-count":20,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2024,12,6]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0313579","relation":{},"ISSN":["1932-6203"],"issn-type":[{"type":"electronic","value":"1932-6203"}],"subject":[],"published":{"date-parts":[[2024,12,6]]}}}